Kave Moloudi | Genetics and Molecular Biology | Research Excellence Award

Posted on by Phenomenological Research Awards

Dr. Kave Moloudi | Genetics and Molecular Biology | Research Excellence Award 

Researcher at University of Caen | France

Dr. Kave Moloudi is a highly accomplished researcher whose scientific contributions in biomedical sciences, molecular biology, and nanotechnology have established him as a rising figure in advanced cancer therapeutics, with a publication record that includes 26 documents, an h-index of 15, and 559 citations by 487 documents. He has cultivated a strong academic foundation through progressive training in biomedical sciences, radiobiology, radiation protection, and medical imaging, supported by extensive laboratory and research experience across multidisciplinary scientific environments. Dr. Kave Moloudi’s academic journey reflects deep engagement with biological systems, cancer mechanisms, and therapeutic innovations, enabling him to bridge fundamental science with translational medical applications. His professional experience spans teaching, research, and laboratory leadership, where he has contributed to scientific advancements in nanomedicine, photodynamic therapy, multimodal imaging, and biomaterials. Throughout his career, he has worked on developing and characterizing nanocarriers, exploring cell death pathways, studying tumor microenvironments, and designing combined therapeutic platforms that integrate photodynamic, radiotherapeutic, and chemotherapeutic strategies. He has also published widely on fluorescent imaging agents, liposomal nanocarriers, radiosensitizers, stem cell responses to ionizing radiation, and the biological effects of natural compounds in oncological contexts. His work often centers on enhancing therapeutic precision, overcoming tumor hypoxia, and improving diagnostic capabilities through innovative imaging modalities. Dr. Kave Moloudi’s research interests span nanotheranostics, 3D cell culture models, cancer imaging, molecular radiobiology, and advanced drug delivery systems, demonstrating a consistent commitment to pushing the boundaries of current therapeutic and diagnostic technologies. His scholarly impact extends globally through numerous peer-reviewed publications, review articles, and collaborative projects that highlight his expertise in integrating nanotechnology with medical science. In conclusion, Dr. Kave Moloudi stands out as a dedicated and forward-thinking scientist whose contributions continue to shape the evolving landscape of cancer research, molecular imaging, and nanomedicine, with his citation metrics and broad research portfolio reflecting both the depth and influence of his academic and scientific achievements.

Profile: Scopus | Orcid | Google Scholar | Linkedin 

Featured Publications:

  • Moloudi, K., Abrahamse, H., & George, B. P. (2024). Nanotechnology-mediated photodynamic therapy: Focus on overcoming tumor hypoxia. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 16(1), e1937.

  • Moloudi, K., Abrahamse, H., & George, B. P. (2025). Overcoming photodynamic therapy resistance via DNA repair inhibitors: Advanced review. Photodiagnosis and Photodynamic Therapy, 54, 104724.

  • Moloudi, K., & Haghdoost, S. (2025). An Update on Role of Ionizing Radiation to Enhance Proliferation and Differentiation of Normal Stem Cells via Activation of NRF2 Pathway: Review. Antioxidants, 14(8), 986.

  • Moloudi, K., Abrahamse, H., & George, B. P. (2023). Photodynamic therapy induced cell cycle arrest and cancer cell synchronization: Review. Oncology (Frontiers in Oncology). 12 July 2023. Frontiers

  • Moloudi, K., Abrahamse, H., & George, B. P. (2024). Co-loading Radio-photosensitizer Agents on Polymer and Lipid-based Nanocarriers for Radio-photodynamic Therapy Purposes: Review. Current Pharmaceutical Design.

  • Moloudi, K., Abrahamse, H., & George, B. P. (2023). Understanding the photodynamic therapy induced bystander and abscopal effects: A review. Antioxidants, 12(7), 1434.

  • Moloudi, K., Abrahamse, H., George, B. P.(2023). Up-regulation of ABCG2 by MYBL2 deletion drives chlorin e6-mediated photodynamic therapy resistance in colorectal cancer. Photodiagnosis and Photodynamic Therapy, 42,

Zipeng Yu | Genetics and Molecular Biology | Best Researcher Award

Posted on by Phenomenological Research Awards

Prof. Zipeng Yu | Genetics and Molecular Biology | Best Researcher Award 

Professor at Shandong University | China

Prof. Zipeng Yu is an accomplished researcher at Shandong University, specializing in plant science with a focus on hormone-mediated growth and stress responses. His career has been defined by a strong commitment to advancing plant biology through innovative studies that connect molecular mechanisms with applied agricultural solutions. Prof. Zipeng Yu has contributed significantly to understanding hormone signaling pathways and their roles in plant adaptation, resilience, and productivity. With an extensive record of publications in leading journals, his work is widely cited and has shaped current directions in plant research, positioning him as a distinguished scholar and innovator in his field.

Profile:

Orcid

Education:

Prof. Zipeng Yu pursued his academic training in plant science and built a strong foundation in molecular biology and biotechnology, which enabled him to integrate cutting-edge techniques into plant hormone research. His education emphasized experimental design, molecular genetics, and cellular signaling pathways, equipping him with the expertise to explore complex biological systems. Through rigorous academic preparation, he has developed both theoretical and practical insights into plant physiology. This strong educational background has been instrumental in guiding his independent research career, enabling him to bridge fundamental science with applied innovations in plant growth, development, and environmental adaptability.

Experience:

Prof. Zipeng Yu has served at Shandong University, where he has actively contributed to teaching, mentoring, and research leadership. His experience spans designing and managing research projects, supervising graduate students, and engaging in collaborative work with national and international partners. He has a proven track record of high-quality research outputs in journals of international repute. Additionally, his professional roles have included active participation in editorial and review processes, contributing to the advancement of scientific standards in plant biology. Through these experiences, he has built a profile as both an educator and a thought leader in his field.

Research Interests:

Prof. Zipeng Yu’s research interests lie in the intricate dynamics of plant hormones and their regulatory mechanisms. His investigations focus on hormone signaling pathways that govern growth, development, and responses to environmental stresses. He is particularly interested in how plants adapt morphologically and physiologically under fluctuating conditions through hormone-mediated plasticity. His work integrates molecular biology, genetics, and physiology, providing a comprehensive view of plant adaptability. Prof. Zipeng Yu’s ongoing projects explore the cross-talk between hormones and stress signaling, offering new insights for improving crop resilience. His contributions are driving forward innovations with broad implications for global agricultural sustainability.

Awards and Honors:

Prof. Zipeng Yu has earned recognition for his outstanding contributions to plant science research, receiving distinctions for both his innovative studies and impactful publications. His awards highlight his dedication to advancing the scientific understanding of hormone-mediated plant processes. He has been honored for excellence in research productivity, scientific innovation, and his influence on plant biology at both national and international levels. These recognitions underscore his leadership, his ability to inspire students and collaborators, and his lasting impact on the global research community. His achievements affirm his place as a highly respected and award-worthy researcher in plant sciences.

Publications:

Title: Cell wall dynamic changes and signaling during plant lateral root development
Year of Publication: 2025
Citation: 2

Title: Cell wall dynamic changes and signaling during plant lateral root development 
Year of Publication: 2025
Citation: 2

Title: Mitogen-Activated Protein Kinases 3/6 Reduce Auxin Signaling via Stabilizing Indoleacetic Acid-Induced Proteins 8/9 in Plant Abiotic Stress Adaptation 
Year of Publication: 2025

Conclusion:

Prof. Zipeng Yu has demonstrated excellence in research, teaching, and scientific innovation, making him a deserving nominee for the Best Researcher Award. His groundbreaking studies on hormone mediated plant growth and stress response have significantly advanced scientific understanding and provided practical insights for sustainable agriculture. With a robust record of impactful publications, citations, and contributions to the global plant science community, he exemplifies the qualities of a pioneering researcher. His dedication to advancing knowledge, mentoring future scientists, and addressing global agricultural challenges highlights his distinguished role in shaping the future of plant biology and its applications.

Kristian Galanti | Genetics and Molecular Biology | Best Researcher Award

Posted on by Phenomenological Research Awards

Dr. Kristian Galanti | Genetics and Molecular Biology | Best Researcher Award

Medico Specializzando at Università degli Studi G. D’Annunzio di Chieti-Pescara | Italy

Dr. Kristian Galanti is a dedicated Resident Doctor in Cardiovascular Diseases and a PhD candidate in Medical Biotechnologies at the University G. D’Annunzio of Chieti-Pescara. He currently serves as a Research Fellow at the Center for Inherited Cardiovascular Disease, WellSpan Health, USA. His clinical interests include heart failure, cardiomyopathies, and cardiovascular imaging. Dr. Galanti demonstrates exceptional commitment to evidence-based care, contributing to both patient management and research. Known for his strong collaborative ethos, he has been actively involved in multidisciplinary case presentations, cardiovascular imaging, and the development of aetiology-oriented diagnostics in cardiology.

Profile:

 Orcid

Education

Dr. Kristian Galanti’s academic journey began with a Master’s Degree in Medicine and Surgery from the Catholic University of the Sacred Heart, Rome, graduating with professional qualification. He undertook further specialization in Cardiovascular Diseases at the University G. D’Annunzio of Chieti-Pescara and is currently pursuing a PhD in Medical Biotechnologies with a focus on technological innovation in cardiovascular sciences. His education is enriched with certifications in cardiac magnetic resonance, echocardiography, and cardiogenetic imaging from leading Italian and European cardiology societies, highlighting his pursuit of continuous learning and academic excellence in clinical and translational cardiology.

Experience:

Dr. Kristian Galanti has significant clinical and research experience. As a resident physician, he managed cardiology cases, conducted ECGs, and performed advanced imaging techniques including echocardiograms and cardiac MRIs. He also participated in interventional procedures, such as angioplasties and device implantations. At WellSpan Health, he contributes to inherited cardiovascular disease research, integrating imaging and genetics to understand arrhythmogenic mitral valve prolapse. He actively engages in writing scientific articles, producing scientific illustrations, and collaborating in multinational studies, making his dual expertise in clinical and research environments a rare and impactful combination.

Research Interest:

Dr. Kristian Galanti’s research centers on cardiovascular imaging, heart failure, and genetic cardiomyopathies. He is particularly focused on multimodality cardiovascular imaging (CMR, echo) and its correlation with genetic markers in diseases like dilated cardiomyopathy and mitral valve prolapse. His current projects involve imaging-genetics integration for arrhythmic risk stratification. Dr. Galanti is also engaged in drug interaction studies related to novel heart failure therapies. Through systematic reviews and original investigations, his work aims to bridge diagnostic precision with therapeutic personalization, making significant contributions to cardiogenetics and translational cardiovascular science.

Awards and Honors:

Dr. Kristian Galanti has earned several accolades for his academic and research contributions. He received the Italian Society of Cardiology Research Grant for excellence in cardiovascular science. Additionally, he was honored with the “Aldo Prosperini” Award for his original research on ejection fraction evaluation. he won the Best Poster Award at the ANMCO MUMA Congress for his clinical case on Cori-Forbes disease. Previous honors include the Clinical Case Award and Best Abstract Award from the Italian Society of Cardiology, along with the prestigious “Iginio Betti” Foundation Scholarship.

Publications:

Title: Diagnosis and management of dilated cardiomyopathy: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Citation: 20

year of Publications: 2024

Title: Arrhythmogenic Cardiomyopathy: Diagnosis and Management

Citation: 18

year of Publications: 2025

Title: Managing drug–drug interactions with mavacamten: a practical guide for clinicians

Citation: 15

year of Publications: 2024

Title: Arrhythmogenic mitral valve prolapse: from clinical features to imaging and genetics

Citation: 10

year of Publications: 2024

Title: Left ventricular non-compaction cardiomyopathy and related phenotypes: diagnosis, prognosis and treatment

Citation: 9

year of Publications: 2025

Title: Current antithrombotic treatments in heart failure: a review

Citation: 7

year of Publications: 2024

Title: Dilated cardiomyopathy evaluation with Imagenomics: combining multimodal cardiovascular imaging and genetics

Citation: 1

year of Publications: 2024

Conclusion:

Dr. Kristian Galanti exemplifies the ideal nominee for a Best Researcher Award. With a solid foundation in clinical cardiology and a progressive academic track in cardiovascular biotechnologies, he combines precision medicine, imaging innovation, and genetic insights in his work. His publication record, international research fellowships, and prestigious recognitions reflect his role as a rising leader in cardiovascular research. Dr. Galanti’s commitment to collaborative science, continual learning, and impactful patient care affirms his readiness to shape the future of cardiovascular medicine with compassion, innovation, and academic rigor.